Your browser doesn't support javascript.
loading
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.
Dane, Eric L; Belessiotis-Richards, Alexis; Backlund, Coralie; Wang, Jianing; Hidaka, Kousuke; Milling, Lauren E; Bhagchandani, Sachin; Melo, Mariane B; Wu, Shengwei; Li, Na; Donahue, Nathan; Ni, Kaiyuan; Ma, Leyuan; Okaniwa, Masanori; Stevens, Molly M; Alexander-Katz, Alfredo; Irvine, Darrell J.
  • Dane EL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Belessiotis-Richards A; Department of Materials, Imperial College London, London, UK.
  • Backlund C; Department of Bioengineering, Imperial College London, London, UK.
  • Wang J; Institute of Biomedical Engineering, Imperial College London, London, UK.
  • Hidaka K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Milling LE; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Bhagchandani S; Immunology Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
  • Melo MB; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Wu S; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Li N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Donahue N; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Ni K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Ma L; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Okaniwa M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Stevens MM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Alexander-Katz A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Mater ; 21(6): 710-720, 2022 06.
Article en En | MEDLINE | ID: mdl-35606429
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article